Zepp Health (ZEPP) Competitors

$10.22 -0.96 (-8.59%)

Closing price 05/15/2026 03:59 PM Eastern

Extended Trading

$10.25 +0.03 (+0.29%)

As of 05/15/2026 05:05 PM Eastern

ZEPP vs. VYX, KOPN, CTLP, SSYS, and CRSR

Should you buy Zepp Health stock or one of its competitors? MarketBeat compares Zepp Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Zepp Health include NCR Voyix (VYX), Kopin (KOPN), Cantaloupe (CTLP), Stratasys (SSYS), and Corsair Gaming (CRSR). These companies are all part of the "computer hardware" industry.

How does Zepp Health compare to NCR Voyix?

Zepp Health (NYSE:ZEPP) and NCR Voyix (NYSE:VYX) are both small-cap computer hardware companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, media sentiment, analyst recommendations, risk and institutional ownership.

NCR Voyix has higher revenue and earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than NCR Voyix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$258.90M	0.58	-$40.07M	-$2.51	N/A
NCR Voyix	$2.69B	0.34	$62M	$0.38	17.51

In the previous week, Zepp Health and Zepp Health both had 2 articles in the media. NCR Voyix's average media sentiment score of 0.62 beat Zepp Health's score of 0.27 indicating that NCR Voyix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zepp Health	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NCR Voyix	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NCR Voyix has a net margin of 2.20% compared to Zepp Health's net margin of -15.48%. NCR Voyix's return on equity of 11.38% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zepp Health	-15.48%	-15.00%	-6.07%
NCR Voyix	2.20%	11.38%	2.58%

52.6% of Zepp Health shares are held by institutional investors. Comparatively, 97.0% of NCR Voyix shares are held by institutional investors. 36.0% of Zepp Health shares are held by company insiders. Comparatively, 0.3% of NCR Voyix shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Zepp Health currently has a consensus price target of $56.28, indicating a potential upside of 450.68%. NCR Voyix has a consensus price target of $13.88, indicating a potential upside of 108.49%. Given Zepp Health's higher possible upside, equities analysts plainly believe Zepp Health is more favorable than NCR Voyix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
NCR Voyix	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

Zepp Health has a beta of 2, meaning that its stock price is 100% more volatile than the broader market. Comparatively, NCR Voyix has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market.

Summary

NCR Voyix beats Zepp Health on 11 of the 15 factors compared between the two stocks.

How does Zepp Health compare to Kopin?

Zepp Health (NYSE:ZEPP) and Kopin (NASDAQ:KOPN) are both small-cap computer hardware companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership.

Kopin has lower revenue, but higher earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than Kopin, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$258.90M	0.58	-$40.07M	-$2.51	N/A
Kopin	$39.32M	23.49	$2.61M	$0.01	505.00

In the previous week, Kopin had 21 more articles in the media than Zepp Health. MarketBeat recorded 23 mentions for Kopin and 2 mentions for Zepp Health. Kopin's average media sentiment score of 0.39 beat Zepp Health's score of 0.27 indicating that Kopin is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zepp Health	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Kopin	3 Very Positive mention(s)	8 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Kopin has a net margin of 5.00% compared to Zepp Health's net margin of -15.48%. Kopin's return on equity of 4.85% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zepp Health	-15.48%	-15.00%	-6.07%
Kopin	5.00%	4.85%	2.36%

52.6% of Zepp Health shares are owned by institutional investors. Comparatively, 31.0% of Kopin shares are owned by institutional investors. 36.0% of Zepp Health shares are owned by company insiders. Comparatively, 2.8% of Kopin shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Zepp Health currently has a consensus price target of $56.28, indicating a potential upside of 450.68%. Kopin has a consensus price target of $7.15, indicating a potential upside of 41.58%. Given Zepp Health's higher probable upside, research analysts clearly believe Zepp Health is more favorable than Kopin.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Kopin	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.86

Zepp Health has a beta of 2, meaning that its share price is 100% more volatile than the broader market. Comparatively, Kopin has a beta of 3.4, meaning that its share price is 240% more volatile than the broader market.

Summary

Kopin beats Zepp Health on 13 of the 17 factors compared between the two stocks.

How does Zepp Health compare to Cantaloupe?

Zepp Health (NYSE:ZEPP) and Cantaloupe (NASDAQ:CTLP) are both small-cap computer hardware companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership.

52.6% of Zepp Health shares are owned by institutional investors. Comparatively, 75.8% of Cantaloupe shares are owned by institutional investors. 36.0% of Zepp Health shares are owned by company insiders. Comparatively, 7.1% of Cantaloupe shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Zepp Health currently has a consensus price target of $56.28, indicating a potential upside of 450.68%. Cantaloupe has a consensus price target of $12.60, indicating a potential upside of 12.50%. Given Zepp Health's higher probable upside, research analysts clearly believe Zepp Health is more favorable than Cantaloupe.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cantaloupe	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cantaloupe has higher revenue and earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than Cantaloupe, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$258.90M	0.58	-$40.07M	-$2.51	N/A
Cantaloupe	$320.82M	2.57	$64.53M	$0.18	62.22

In the previous week, Zepp Health and Zepp Health both had 2 articles in the media. Cantaloupe's average media sentiment score of 0.93 beat Zepp Health's score of 0.27 indicating that Cantaloupe is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zepp Health	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cantaloupe	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cantaloupe has a net margin of 1.15% compared to Zepp Health's net margin of -15.48%. Cantaloupe's return on equity of 4.94% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zepp Health	-15.48%	-15.00%	-6.07%
Cantaloupe	1.15%	4.94%	3.22%

Zepp Health has a beta of 2, meaning that its share price is 100% more volatile than the broader market. Comparatively, Cantaloupe has a beta of 1, meaning that its share price has a similar volatility profile to the broader market.

Summary

Cantaloupe beats Zepp Health on 10 of the 13 factors compared between the two stocks.

How does Zepp Health compare to Stratasys?

Stratasys (NASDAQ:SSYS) and Zepp Health (NYSE:ZEPP) are both small-cap computer hardware companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

75.8% of Stratasys shares are owned by institutional investors. Comparatively, 52.6% of Zepp Health shares are owned by institutional investors. 4.3% of Stratasys shares are owned by insiders. Comparatively, 36.0% of Zepp Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Stratasys presently has a consensus price target of $12.33, indicating a potential upside of 44.08%. Zepp Health has a consensus price target of $56.28, indicating a potential upside of 450.68%. Given Zepp Health's higher probable upside, analysts clearly believe Zepp Health is more favorable than Stratasys.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stratasys	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Zepp Health has lower revenue, but higher earnings than Stratasys. Stratasys is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stratasys	$551.10M	1.34	-$104.29M	-$1.35	N/A
Zepp Health	$258.90M	0.58	-$40.07M	-$2.51	N/A

In the previous week, Stratasys had 3 more articles in the media than Zepp Health. MarketBeat recorded 5 mentions for Stratasys and 2 mentions for Zepp Health. Stratasys' average media sentiment score of 1.12 beat Zepp Health's score of 0.27 indicating that Stratasys is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stratasys	1 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zepp Health	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Zepp Health has a net margin of -15.48% compared to Stratasys' net margin of -21.00%. Stratasys' return on equity of -1.73% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stratasys	-21.00%	-1.73%	-1.35%
Zepp Health	-15.48%	-15.00%	-6.07%

Stratasys has a beta of 1.86, indicating that its stock price is 86% more volatile than the broader market. Comparatively, Zepp Health has a beta of 2, indicating that its stock price is 100% more volatile than the broader market.

Summary

Stratasys beats Zepp Health on 10 of the 16 factors compared between the two stocks.

How does Zepp Health compare to Corsair Gaming?

Corsair Gaming (NASDAQ:CRSR) and Zepp Health (NYSE:ZEPP) are both small-cap computer hardware companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

In the previous week, Corsair Gaming had 5 more articles in the media than Zepp Health. MarketBeat recorded 7 mentions for Corsair Gaming and 2 mentions for Zepp Health. Corsair Gaming's average media sentiment score of 0.69 beat Zepp Health's score of 0.27 indicating that Corsair Gaming is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Corsair Gaming	1 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zepp Health	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

25.7% of Corsair Gaming shares are held by institutional investors. Comparatively, 52.6% of Zepp Health shares are held by institutional investors. 58.4% of Corsair Gaming shares are held by insiders. Comparatively, 36.0% of Zepp Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Corsair Gaming has a net margin of 0.71% compared to Zepp Health's net margin of -15.48%. Corsair Gaming's return on equity of 9.71% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Corsair Gaming	0.71%	9.71%	4.97%
Zepp Health	-15.48%	-15.00%	-6.07%

Corsair Gaming has higher revenue and earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than Corsair Gaming, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Corsair Gaming	$1.47B	0.49	-$12.47M	$0.08	84.00
Zepp Health	$258.90M	0.58	-$40.07M	-$2.51	N/A

Corsair Gaming presently has a consensus price target of $8.33, suggesting a potential upside of 24.01%. Zepp Health has a consensus price target of $56.28, suggesting a potential upside of 450.68%. Given Zepp Health's higher possible upside, analysts clearly believe Zepp Health is more favorable than Corsair Gaming.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Corsair Gaming	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Corsair Gaming has a beta of 1.59, meaning that its stock price is 59% more volatile than the broader market. Comparatively, Zepp Health has a beta of 2, meaning that its stock price is 100% more volatile than the broader market.

Summary

Corsair Gaming beats Zepp Health on 12 of the 16 factors compared between the two stocks.

Get Zepp Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZEPP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZEPP vs. The Competition

Export

Metric	Zepp Health	MEDICAL INFO SYS Industry	Medical Sector	NYSE Exchange
Market Cap	$150.47M	$1.41B	$6.38B	$22.77B
Dividend Yield	N/A	N/A	2.81%	4.13%
P/E Ratio	-4.07	63.83	20.64	29.73
Price / Sales	0.58	6.01	554.15	23.38
Price / Cash	N/A	22.75	42.43	24.78
Price / Book	0.69	5.98	9.87	4.60
Net Income	-$40.07M	-$54.76M	$3.57B	$1.07B
7 Day Performance	-17.01%	-0.92%	0.23%	-2.27%
1 Month Performance	-37.72%	4.01%	-2.54%	-1.66%
1 Year Performance	266.97%	-8.68%	33.54%	21.95%

Zepp Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZEPP Zepp Health	2.7495 of 5 stars	$10.22 -8.6%	$56.28 +450.7%	+267.0%	$150.47M	$258.90M	N/A	1,230	Upcoming Earnings
VYX NCR Voyix	3.3813 of 5 stars	$7.19 -0.1%	$13.75 +91.4%	-38.9%	$997.54M	$2.69B	24.75	13,500
KOPN Kopin	3.4633 of 5 stars	$4.61 +3.1%	$5.15 +11.8%	+241.2%	$827.88M	$38.47M	451.95	180	Earnings Report Analyst Forecast Gap Down High Trading Volume
CTLP Cantaloupe	1.247 of 5 stars	$11.19 0.0%	$12.60 +12.7%	+31.9%	$824.56M	$317.56M	62.14	220
SSYS Stratasys	3.4034 of 5 stars	$8.98 +2.7%	$12.33 +37.4%	-23.3%	$773.58M	$551.10M	N/A	1,757

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ZEPP) was last updated on 5/17/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zepp Health (ZEPP) Competitors

ZEPP vs. VYX, KOPN, CTLP, SSYS, and CRSR

How does Zepp Health compare to NCR Voyix?

Summary

How does Zepp Health compare to Kopin?

Summary

How does Zepp Health compare to Cantaloupe?

Summary

How does Zepp Health compare to Stratasys?

Summary

How does Zepp Health compare to Corsair Gaming?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZEPP vs. The Competition

Zepp Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Zepp Health (ZEPP) Competitors

ZEPP vs. VYX, KOPN, CTLP, SSYS, and CRSR

How does Zepp Health compare to NCR Voyix?

Which has better earnings & valuation, ZEPP or VYX?

Does the media refer more to ZEPP or VYX?

Is ZEPP or VYX more profitable?

Do institutionals and insiders have more ownership in ZEPP or VYX?

Do analysts recommend ZEPP or VYX?

Which has more volatility and risk, ZEPP or VYX?

Summary

How does Zepp Health compare to Kopin?

Which has preferable earnings and valuation, ZEPP or KOPN?

Does the media refer more to ZEPP or KOPN?

Is ZEPP or KOPN more profitable?

Do insiders & institutionals have more ownership in ZEPP or KOPN?

Do analysts recommend ZEPP or KOPN?

Which has more risk and volatility, ZEPP or KOPN?

Summary

How does Zepp Health compare to Cantaloupe?

Do insiders & institutionals have more ownership in ZEPP or CTLP?

Do analysts recommend ZEPP or CTLP?

Which has preferable earnings and valuation, ZEPP or CTLP?

Does the media refer more to ZEPP or CTLP?

Is ZEPP or CTLP more profitable?

Which has more risk and volatility, ZEPP or CTLP?

Summary

How does Zepp Health compare to Stratasys?

Do institutionals & insiders have more ownership in SSYS or ZEPP?

Do analysts prefer SSYS or ZEPP?

Which has higher earnings & valuation, SSYS or ZEPP?

Does the media prefer SSYS or ZEPP?

Is SSYS or ZEPP more profitable?

Which has more risk & volatility, SSYS or ZEPP?

Summary

How does Zepp Health compare to Corsair Gaming?

Does the media favor CRSR or ZEPP?

Do insiders and institutionals have more ownership in CRSR or ZEPP?

Is CRSR or ZEPP more profitable?

Which has better valuation & earnings, CRSR or ZEPP?

Do analysts rate CRSR or ZEPP?

Which has more volatility & risk, CRSR or ZEPP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZEPP vs. The Competition

Zepp Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools